Additional observations include shifts in enzyme activity, substrate utilization, and mitochondrial function, reflecting the broader influence of growth hormone axis activation
Better health begins here No insurance required No memberships or hidden fees Pay only after your appointment Important Safety Information GLP-1 agonists, including Wegovy, Zepbound, and Saxenda, may cause serious side effects including possible thyroid tumors, including cancer
In the interim, continued shared decision making with patients and clinical vigilance for pancreatic diseases in patients on GLP-1RA therapy remains prudent
The Facts: Better care starts with better listening
This allows us to dissect risk, correct underlying issues and restore vital health
Gastrointestinal side effects from GLP-1 receptor agonists usually improve within 48 weeks as tolerance develops